Abstract
Various imaging modalities are used in conjunction with visual fields and clinical examination of glaucoma patients. OCT like other imaging modalities typically compare patient images to a normative database and present structure characteristics that are outside of normal for age-matched controls in red lettering or boxes, whereas structure characteristics within the normal range are presented in green. Although optical coherence tomography (OCT) is currently an important adjunct to clinical diagnosis, normative databases do not contain examples of atypical optic nerve head or retinal nerve fiber layer morphologies and can therefore flag these findings as abnormal. Furthermore, imaging can provide artifacts which do not represent true ocular disease but are secondary to limitations of imaging technology. Recognition of false-positive “Red Disease” and false-negative “Green Disease” is of importance in diagnosing and treating glaucoma. In this section we provide examples for ‘Red disease’ and ‘Green Disease’ and the artifacts that may affect diagnostic performance of the spectral domain OCT.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Leung CK, et al. Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: interpreting the RNFL maps in healthy myopic eyes. Invest Ophthalmol Vis Sci. 2012;53(11):7194–200.
Hood DC, et al. The location of the inferior and superior temporal blood vessels and inter-individual variability of the retinal nerve fiber layer thickness. J Glaucoma. 2010;19(3):158.
Jonas, R.A., et al., Optic disc-fovea angle: the Beijing Eye Study 2011. PLoS One, 2015;10(11).
Acknowledgments
Funding/Support: Supported in part by National Institutes of Health/National Eye Institute grants R01 EY029058 (RNW), by core grant P30EY022589; by an unrestricted grant from Research to Prevent Blindness (New York, NY); by grants for participants’ glaucoma medications from Alcon, Allergan, Pfizer, Merck, and Santen, and by the donors of the National Glaucoma Research Program, a program of the BrightFocus Foundation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Moghimi, S., SafiZadeh, M., Camp, A., Weinreb, R.N. (2021). OCT Artifacts in Glaucoma. In: Mohammadpour, M. (eds) Diagnostics in Ocular Imaging. Springer, Cham. https://doi.org/10.1007/978-3-030-54863-6_27
Download citation
DOI: https://doi.org/10.1007/978-3-030-54863-6_27
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-54862-9
Online ISBN: 978-3-030-54863-6
eBook Packages: MedicineMedicine (R0)